Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE (www.oxfordhandbooks.com). © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 June 2018

Abstract and Keywords

The illness causes patients to suffer from increasingly severe and widespread dysfunction of the central nervous system leading to disturbances of sleep, sense of smell, autonomic function, cognition, motivation, and mood, as well as decision making and personality. This article concerns the genetics of Parkinson's disease (PD), functional imaging including imaging of pre-symptomatic subjects, and treatment of Parkinsonian diseases including novel treatments, side effects, the placebo effect, potential biases in the evaluation and promotion of therapies, and access to resources as examples of the numerous and varied ethical challenges associated with this neurodegenerative disorder. There are several issues encountered in the management of patients with PD in which ethical considerations may be important.

Keywords: Parkinson's disease, novel treatments, neurodegenerative disorder, ethical challenges, management

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.